Health
Post-Vax Clot Case Supports Angiomax Use – MedPage Today
This might be a good non-heparin alternative, docs say
Bivalirudin (Angiomax) worked for one of the very rare cases of blood clots with low platelets after vaccination against COVID-19, researchers reported.
The 40-year-old woman presented with a headache on the same day that the CDC and FDA hit pause on use of the Johnson & Johnson vaccine over risk of what’s being dubbed vaccine-induced thrombotic thrombocytopenia (VITT) or thrombosis with thrombocytopenia syndrome (TTS).
She developed a headache, sinus pressure, myalgias, and sore throat with tonsillar…
-
General13 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News13 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
Noosa News22 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General19 hours agoCrowe toasts talkback titan for platforming ‘voiceless’